Lucky Mart Inc. issues voluntary nationwide recall of Piyanping Anti-Itch Lotion due to incorrect active ingredient.
Lucky Mart Inc. is voluntarily recalling lots C14005, C16001 and C16002 of Piyanping Anti-Itch Lotion to the consumer level. The product was manufactured using the active pharmaceutical ingredient dexamethasone rather than hydrocortisone. Dexamethasone is not listed as an ingredient in the labeling.
Dexamethasone is a higher potency steroid than hydrocortisone and may have a longer half-life; it could potentially cause serious side effects in patients applying the cream multiple times daily. There is a reasonable probability of any or all of the following side effects of topical steroids which include but are not limited to skin changes (whitening, thinning), adrenal suppression (high blood sugar, weakened immunity, electrolyte imbalances, emotional lability, slowing of growth in children), glaucoma, and cataracts. To date Lucky Mart Inc. has not received any reports of adverse events related to this recall.
The product is an itch lotion and is indicated for the temporary relief of itching associated with minor skin irritations, inflammation, and rashes in adults and children ages two and older. Products are packaged in a 0.67 oz (20g) tube in a paper carton. Lots C14005 (Exp. 03/2017), C16001 (Exp. 12/2018), C16002 (Exp. 12/2018). NDC 68085-8012-4. Piyanping Anti-Itch Lotion was distributed Nationwide in the USA to herbal and ethnic grocery stores. Lot # and Expiration Date can be found on the right side of the box, opposite of the barcode.
Lucky Mart Inc. is notifying its distributors and customers about the recall by letter and arranging for return by UPS; additionally, they are visiting local customers in person to collect product. Consumers that may have product which is being recalled should stop use and return to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
(Source: FDA)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
